{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T22:37:19Z","timestamp":1792103839922,"version":"4.4.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T00:00:00Z","timestamp":1767398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T00:00:00Z","timestamp":1769644800000},"content-version":"vor","delay-in-days":26,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-025-04488-5","type":"journal-article","created":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T07:12:53Z","timestamp":1767424373000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Analysis of the incidence and risk factors of colorectal polyps in patients with chronic hepatitis B complicated by non - alcoholic fatty liver disease"],"prefix":"10.1186","volume":"26","author":[{"given":"Lin","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-wen","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-jiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng-yu","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-zhou","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhan-hong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing-ping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,3]]},"reference":[{"issue":"03","key":"4488_CR1","first-page":"457","volume":"26","author":"H You","year":"2023","unstructured":"You H, Wang FS, Li TS, et al. Guidelines for the prevention and treatment of chronic hepatitis B (2022 Edition). J Practical Hepatol. 2023;26(03):457\u201378.","journal-title":"J Practical Hepatol"},{"issue":"04","key":"4488_CR2","first-page":"494","volume":"27","author":"JG Fan","year":"2024","unstructured":"Fan JG, Xu XY, Nan YM, et al. Guidelines for the prevention and treatment of metabolic dysfunction - associated (non - alcoholic) fatty liver disease (Version 2024). J Practical Hepatol. 2024;27(04):494\u2013510.","journal-title":"J Practical Hepatol"},{"issue":"3","key":"4488_CR3","first-page":"141","volume":"34","author":"MF Wang","year":"2016","unstructured":"Wang MF, Lin S, Wu LL, et al. Relationship between hepatic steatosis and viral factors in serum and liver tissue in patients with chronic hepatitis B. Chin J Infect Dis. 2016;34(3):141\u20135.","journal-title":"Chin J Infect Dis"},{"issue":"04","key":"4488_CR4","first-page":"706","volume":"14","author":"Oncology Branch of Chinese Medical Association, Department of Medical Administration of the National Health Commission","year":"2023","unstructured":"Oncology Branch of Chinese Medical Association, Department of Medical Administration of the National Health Commission. Chinese Colorectal Cancer Diagnosis and Treatment Specification (2023 Edition). Med J Peking Union Med Coll Hosp. 2023;14(04):706\u201333.","journal-title":"Med J Peking Union Med Coll Hosp"},{"key":"4488_CR5","doi-asserted-by":"publisher","first-page":"1141956","DOI":"10.3389\/fimmu.2023.1141956","volume":"14","author":"Y Min","year":"2023","unstructured":"Min Y, Wei X, Xia X, et al. Hepatitis B virus infection: an insight into the clinical connection and molecular interaction between hepatitis B virus and host extrahepatic cancer risk. Front Immunol. 2023;14:1141956.","journal-title":"Front Immunol"},{"issue":"5","key":"4488_CR6","first-page":"492","volume":"6","author":"BB Patel","year":"2015","unstructured":"Patel BB, Lipka S, Shen H, Davis-Yadley AH, Viswanathan P. Establishing the link between hepatitis B virus infection and colorectal adenoma. J Gastrointest Oncol. 2015;6(5):492\u20137.","journal-title":"J Gastrointest Oncol"},{"issue":"2","key":"4488_CR7","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.amjms.2018.04.016","volume":"356","author":"SH Kim","year":"2018","unstructured":"Kim SH, Kim JW, Lee KL, et al. Hepatitis B virus infection is independently associated with advanced colorectal adenoma. Am J Med Sci. 2018;356(2):141\u20136.","journal-title":"Am J Med Sci"},{"issue":"12","key":"4488_CR8","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1097\/MEG.0000000000002636","volume":"35","author":"Y Yang","year":"2023","unstructured":"Yang Y, Teng Y, Shi J, et al. Association of nonalcoholic fatty liver disease with colorectal adenomatous polyps and non-adenomatous polyps: a cross-sectional study. Eur J Gastroenterol Hepatol. 2023;35(12):1389\u201393.","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"3","key":"4488_CR9","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"key":"4488_CR10","doi-asserted-by":"publisher","first-page":"1068432","DOI":"10.3389\/fphar.2022.1068432","volume":"13","author":"S Ye","year":"2022","unstructured":"Ye S, Liu Y, Zhang T, Feng H, Liu Y, Ma L. Analysis of the correlation between non-alcoholic fatty liver disease and the risk of colorectal neoplasms. Front Pharmacol. 2022;13:1068432.","journal-title":"Front Pharmacol"},{"issue":"11","key":"4488_CR11","first-page":"1431","volume":"34","author":"HW Liu","year":"2022","unstructured":"Liu HW, Wang XX, Zhao D, et al. Analysis of risk factors for colorectal polyps and their relationship with Non - alcoholic fatty liver disease. Mod Practical Med. 2022;34(11):1431\u20134.","journal-title":"Mod Practical Med"},{"key":"4488_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1368965","volume":"14","author":"JF Zhao","year":"2024","unstructured":"Zhao JF, Zhou BG, Lv Y, et al. Association between metabolic dysfunction-associated steatotic liver disease and risk of colorectal cancer or colorectal adenoma: an updated meta-analysis of cohort studies. Front Oncol. 2024;14:1368965.","journal-title":"Front Oncol"},{"issue":"1","key":"4488_CR13","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/ajg.2009.541","volume":"105","author":"HW Kang","year":"2010","unstructured":"Kang HW, Kim D, Kim HJ, et al. Visceral obesity and insulin resistance as risk factors for colorectal adenoma: a cross-sectional, case-control study. Am J Gastroenterol. 2010;105(1):178\u201387.","journal-title":"Am J Gastroenterol"},{"issue":"22","key":"4488_CR14","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1093\/jnci\/dji376","volume":"97","author":"EK Wei","year":"2005","unstructured":"Wei EK, Giovannucci E, Fuchs CS, Willett WC, Mantzoros CS. Low plasma adiponectin levels and risk of colorectal cancer in men: a prospective study. J Natl Cancer Inst. 2005;97(22):1688\u201394.","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"4488_CR15","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1002\/hep.30429","volume":"70","author":"RS Khan","year":"2019","unstructured":"Khan RS, Bril F, Cusi K, Newsome PN. Modulation of insulin resistance in nonalcoholic fatty liver disease. Hepatology. 2019;70(2):711\u201324.","journal-title":"Hepatology"},{"issue":"2","key":"4488_CR16","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1080\/03602532.2017.1293683","volume":"49","author":"E Cobbina","year":"2017","unstructured":"Cobbina E, Akhlaghi F. Non-alcoholic fatty liver disease (NAFLD) - pathogenesis, classification, and effect on drug metabolizing enzymes and transporters. Drug Metab Rev. 2017;49(2):197\u2013211.","journal-title":"Drug Metab Rev"},{"issue":"8","key":"4488_CR17","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1016\/j.metabol.2015.11.006","volume":"65","author":"SA Polyzos","year":"2016","unstructured":"Polyzos SA, Kountouras J, Mantzoros CS. Adipokines in nonalcoholic fatty liver disease. Metabolism. 2016;65(8):1062\u201379.","journal-title":"Metabolism"},{"issue":"8","key":"4488_CR18","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1007\/s00018-019-03011-w","volume":"76","author":"Z Safari","year":"2019","unstructured":"Safari Z, G\u00e9rard P. The links between the gut microbiome and non-alcoholic fatty liver disease (NAFLD). Cell Mol Life Sci. 2019;76(8):1541\u201358.","journal-title":"Cell Mol Life Sci"},{"issue":"06","key":"4488_CR19","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/S1499-3872(15)60026-1","volume":"14","author":"P Gkolfakis","year":"2015","unstructured":"Gkolfakis P, Dimitriadis G, Triantafyllou K. Gut microbiota and non-alcoholic fatty liver disease. Hepatob Pancreat Dis. 2015;14(06):572\u201381.","journal-title":"Hepatob Pancreat Dis"},{"issue":"11","key":"4488_CR20","doi-asserted-by":"publisher","first-page":"2786","DOI":"10.1099\/jgv.0.000958","volume":"98","author":"JH Choi","year":"2017","unstructured":"Choi JH, Jeong H, Jang KL. Hepatitis B virus X protein suppresses all-trans retinoic acid-induced apoptosis in human hepatocytes by repressing p14 expression via DNA methylation. J Gen Virol. 2017;98(11):2786\u201398.","journal-title":"J Gen Virol"},{"issue":"8","key":"4488_CR21","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1111\/j.1537-2995.2012.03575.x","volume":"52","author":"MK Arababadi","year":"2012","unstructured":"Arababadi MK, Nasiri Ahmadabadi B, Kennedy D. Current information on the immunologic status of occult hepatitis B infection. Transfusion. 2012;52(8):1819\u201326.","journal-title":"Transfusion"},{"issue":"12","key":"4488_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8122085","volume":"8","author":"YS Jung","year":"2019","unstructured":"Jung YS, Kim NH, Park JH, Park DI, Sohn CI. Correlation between hepatitis B virus infection and colorectal neoplasia. J Clin Med. 2019;8(12):2085.","journal-title":"J Clin Med"},{"issue":"3","key":"4488_CR23","doi-asserted-by":"publisher","first-page":"714","DOI":"10.4314\/ahs.v15i3.3","volume":"15","author":"B Yilmaz","year":"2015","unstructured":"Yilmaz B, Koklu S, Buyukbayram H, et al. Chronic hepatitis B associated with hepatic steatosis, insulin resistance, necroinflammation and fibrosis. Afr Health Sci. 2015;15(3):714\u20138.","journal-title":"Afr Health Sci"},{"issue":"46","key":"4488_CR24","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000017945","volume":"98","author":"L Liu","year":"2019","unstructured":"Liu L, Li P, Mi Y, Liu Y, Liu Y, Zhang P. Thyroid-stimulating hormone is associated with nonalcoholic steatohepatitis in patients with chronic hepatitis B. Medicine (Baltimore). 2019;98(46):e17945.","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"4488_CR25","doi-asserted-by":"publisher","first-page":"399","DOI":"10.5009\/gnl19097","volume":"14","author":"Y Hao","year":"2020","unstructured":"Hao Y, Wang Y, Qi M, He X, Zhu Y, Hong J. Risk factors for recurrent colorectal polyps. Gut Liver. 2020;14(4):399\u2013411.","journal-title":"Gut Liver"},{"issue":"5","key":"4488_CR26","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1055\/s-2006-925227","volume":"38","author":"DI Park","year":"2006","unstructured":"Park DI, Kim YH, Kim HS, et al. Diagnostic yield of advanced colorectal neoplasia at colonoscopy, according to indications: an investigation from the Korean association for the study of intestinal diseases (KASID). Endoscopy. 2006;38(5):449\u201355.","journal-title":"Endoscopy"},{"issue":"6","key":"4488_CR27","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1007\/s00384-012-1628-y","volume":"28","author":"PA Foster","year":"2013","unstructured":"Foster PA. Oestrogen and colorectal cancer: mechanisms and controversies. Int J Colorectal Dis. 2013;28(6):737\u201349.","journal-title":"Int J Colorectal Dis"},{"issue":"1","key":"4488_CR28","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1158\/1055-9965.EPI-13-0733","volume":"23","author":"A Fonseca-Nunes","year":"2014","unstructured":"Fonseca-Nunes A, Jakszyn P, Agudo A. Iron and cancer risk\u2013a systematic review and meta-analysis of the epidemiological evidence. Cancer Epidemiol Biomarkers Prev. 2014;23(1):12\u201331.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"12","key":"4488_CR29","first-page":"1472","volume":"28","author":"ZS Hu","year":"2023","unstructured":"Hu ZS, Yao YY, Jin J, et al. Relationship among NAFLD, Hp infection and colorectal polyps. Chin Hepatol. 2023;28(12):1472\u20135.","journal-title":"Chin Hepatol"},{"issue":"01","key":"4488_CR30","first-page":"58","volume":"42","author":"XP Yang","year":"2021","unstructured":"Yang XP, Zhan L, Wang YL, et al. Analysis of risk factors for colorectal polyps and their correlation with Non - alcoholic fatty liver disease. Sichuan Med J. 2021;42(01):58\u201362.","journal-title":"Sichuan Med J"},{"issue":"19","key":"4488_CR31","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1001\/jama.2019.3076","volume":"321","author":"RGS Meester","year":"2019","unstructured":"Meester RGS, Mannalithara A, Lansdorp-Vogelaar I, Ladabaum U. Trends in incidence and stage at diagnosis of colorectal cancer in adults aged 40 through 49 years, 1975\u20132015. JAMA. 2019;321(19):1933\u20134.","journal-title":"JAMA"},{"key":"4488_CR32","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s12902-019-0444-6","volume":"19","author":"G Soltani","year":"2019","unstructured":"Soltani G, Poursheikhani A, Yassi M, Hayatbakhsh A, Kerachian M, Kerachian MA. Obesity, diabetes and the risk of colorectal adenoma and cancer. BMC Endocr Disord. 2019;19:113.","journal-title":"BMC Endocr Disord"},{"key":"4488_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.683872","volume":"8","author":"Y Zheng","year":"2021","unstructured":"Zheng Y, Xu K, Hu H, Draz MS, Wu W, Li L. Prevalence and incidence of non-alcohol fatty liver disease in chronic hepatitis B population in Southeast China: a community-based study. Front Med (Lausanne). 2021;8:683872.","journal-title":"Front Med (Lausanne)"},{"issue":"1","key":"4488_CR34","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1186\/s12944-025-02679-3","volume":"24","author":"M Li","year":"2025","unstructured":"Li M, Wan Y, Wang N, et al. Sex-specific association of novel complex inflammatory markers with colorectal polyps: mediating effects of triglyceride-glucose and non-high-density lipoprotein cholesterol. Lipids Health Dis. 2025;24(1):276.","journal-title":"Lipids Health Dis"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-025-04488-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-04488-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-04488-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T14:21:55Z","timestamp":1769696515000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12876-025-04488-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,3]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4488"],"URL":"https:\/\/doi.org\/10.1186\/s12876-025-04488-5","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,3]]},"assertion":[{"value":"28 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All patients provided informed consent and agreed to participate in the study.This study was approved by the Institutional Review Board of Tianjin Tianjin Second People\u2019s Hospital and was conducted according to the Declaration of Helsinki.Approval Number: The Second People\u2019s Hospital Ethics Review [2025] No. 8.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"77"}}